Literature DB >> 9503408

[Development of KRN7000, derived from agelasphin produced by Okinawan sponge].

T Natori1, K Akimoto, K Motoki, Y Koezuka, T Higa.   

Abstract

New glycosphingolipids, named agelasphins, have been isolated as antitumoral compounds from an extract of a marine sponge, Agelas mauritianus. The absolute configurations of agelasphins were elucidated by the total synthesis. Various analogues of agelasphins were also synthesized and the relationship between their structures and biological activities was examined using an MLR assay. From the results, KRN7000, (2S,3S,4R)-1-O-(alpha-D- galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol , was selected as a candidate for clinical application. KRN7000 markedly stimulated lymphocytic proliferation in allogeneic MLR, and showed potent tumor growth inhibitory activities in B16-bearing mice and strongly inhibited tumor metastasis, suggesting that KRN7000 is a potent biological response modifier. These biological effects were exerted by the activation of dendritic cells by KRN7000.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9503408     DOI: 10.1254/fpj.110.supplement_63

Source DB:  PubMed          Journal:  Nihon Yakurigaku Zasshi        ISSN: 0015-5691


  4 in total

Review 1.  How do natural killer T cells help B cells?

Authors:  Mark L Lang
Journal:  Expert Rev Vaccines       Date:  2009-08       Impact factor: 5.217

Review 2.  Activation strategies for invariant natural killer T cells.

Authors:  Ayano C Kohlgruber; Carlos A Donado; Nelson M LaMarche; Michael B Brenner; Patrick J Brennan
Journal:  Immunogenetics       Date:  2016-07-25       Impact factor: 2.846

3.  Boosting the Immune Response: The Use of iNKT cell ligands as vaccine adjuvants.

Authors:  Priyanka Subrahmanyam; Tonya J Webb
Journal:  Front Biol (Beijing)       Date:  2012-10-01

4.  An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses.

Authors:  Stephanie Longet; Aine Abautret-Daly; Sukanya Raghavan; Ed C Lavelle; Christopher J H Davitt; Craig P McEntee; Vincenzo Aversa; Monica Rosa; Ivan S Coulter; Jan Holmgren
Journal:  NPJ Vaccines       Date:  2019-10-25       Impact factor: 7.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.